GO with more
GOOD ON time
Treat dyskinesia and OFF time without compromising on either. GOCOVRI® is the only medication proven to reduce both in patients with Parkinson's disease for more GOOD ON time. Just 1 nightly dose can mean all-day coverage.1,2
Kendall, GOCOVRI patient.
Hear from real clinicians prescribing GOCOVRI
The daily impact of dyskinesia and OFF time
See the challenges real people with Parkinson’s disease face, as well as some strategies for identifying and managing dyskinesia and OFF time.
"It's my belief that we need to shift the paradigm, to focus on giving patients GOOD ON time as consistently as possible throughout the day without disruptions." –Dr. Isaacson
Who is GOCOVRI right for?
Explore 2 case vignettes that represent patients commonly seen in clinical practice and discover what more GOOD ON time means to them.
"With a better understanding of how dyskinesia and OFF affect patients, we may be able to make more informed treatment decisions." –Dr. Hauser
Proven results in short-term studies and evaluated in a long-term OLE study
GOCOVRI was studied in a 12-week Phase 3 trial, a 24-week Phase 3 trial, and a long-term OLE study.1,3
1 nightly dose for all-day medication coverage
GOCOVRI is formulated to release slowly while your patients sleep and gradually increases plasma concentrations until the morning.2
Get going with GOCOVRI
With a high claims approval rate, it's easy to get your patients started with GOCOVRI Onboard®.
Why consider GOCOVRI?
With GOCOVRI, you don’t have to accept a trade-off between dyskinesia and OFF time. Take a closer look at how GOCOVRI works to treat both dyskinesia and OFF time in patients like yours.
Get clinical information on GOCOVRI
Get the latest news and updates about GOCOVRI®, learn about upcoming events, and more.